Qiagen NV | QIA - Operating Profit

Stock Price
35.15
Daily Change
-0.45 -1.25%
Monthly
-14.24%
Yearly
-3.26%
Q1 Forecast
35.13

Qiagen NV reported $121.88M in Operating Profit for its fiscal quarter ending in December of 2025.





Operating Profit Change Date
Akebia Therapeutics USD -5.45M 9.4M Dec/2025
Alaunos Therapeutics USD -1.19M 148K Sep/2025
argenx SE USD 371.14M 21.17M Dec/2025
Avita Medical AUD -10.41M 742K Dec/2025
Dianthus Therapeutics USD -69.54M 29.25M Dec/2025
Ionis Pharmaceuticals USD -215M 54.82M Dec/2025
IQVIA Holdings USD 2.68B 2.1B Dec/2025
Moderna USD -857M 597M Dec/2025
Organon & Co USD 388M 62M Sep/2025
Qiagen NV USD 121.88M 15.41M Dec/2025
Revvity USD 145.83M 47.49M Dec/2025
Tectonic Therapeutic USD -21.52M 374K Dec/2025
Viatris USD -157.5M 392M Dec/2025
Xeris Pharmaceuticals USD 16.77M 10.04M Dec/2025